查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1807098

全球無細胞蛋白表達市場成長、規模和趨勢分析（按產品、應用、方法和最終用戶）- 區域展望、競爭策略和細分預測（至2034年）

Global Cell- Free Protein Expression Market Growth, Size, Trends Analysis - By Product, By Application, By Method, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 262 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到2034年全球無細胞蛋白表現市場規模將達到 6.8032億美元，年複合成長率為 8.86%。

無細胞蛋白質表現技術允許在試管內中合成蛋白質，而無需使用活細胞。此技術不依賴整個生物體的細胞機制，而是利用從大腸桿菌、麥胚或昆蟲細胞等細菌中提取的核醣體、tRNA、胺基酸和酵素等成分。這些成分保留了將 DNA 轉錄為 RNA 並將 RNA 翻譯為蛋白質的能力，使研究人員能夠在受控環境中快速生產蛋白質。

阻礙因素：全球無細胞蛋白表現市場擴充性有限，是一大挑戰。雖然無細胞系統在小規模應用方面效果良好，但難以達到工業化生產所需的高產量。因此，由於需要進行大量的最佳化並使用大量昂貴的試劑，大規模合成在經濟上面臨挑戰。

本報告調查了全球無細胞蛋白表達市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章 引言

第2章 調查方法

第3章 執行摘要

第4章 市場動態

  • 促進因素、阻礙因素、機會與挑戰分析

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭態勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、合作夥伴關係、產品發布和合作

第7章 全球無細胞蛋白質表現市場（依產品）

  • 表達系統
  • 試劑

第8章 全球無細胞蛋白質表現市場（依應用）

  • 酵素工程
  • 高通量生產
  • 蛋白質標記
  • 蛋白質-蛋白質相互作用
  • 蛋白質純化

第9章 全球無細胞蛋白質表現市場（依方法）

  • 轉錄和翻譯系統
  • 翻譯系統

第10章 全球無細胞蛋白質表現市場（依最終用戶）

  • 製藥和生物技術公司
  • 學術研究機構
  • 其他

第11章 全球無細胞蛋白質表現市場

  • 全球市場規模和市場佔有率

第12章 全球無細胞蛋白質表現市場（依地區）

  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亞
    • 其他
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美國
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他

第13章 公司簡介

  • biotechrabbit
  • CellFree Sciences Co., Ltd
  • GeneCopoeia, Inc.
  • Jena Bioscience GmbH
  • Merck KGaA,
  • New England Biolabs
  • Promega Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • 其他

第14章 結論

第15章 簡稱列表

第16章 參考鏈接

簡介目錄
Product Code: HLCA25235

Global Cell-Free Protein Expression Market Introduction and Overview

According to SPER market research, 'Global Cell-Free Protein Expression Market Size-By Product, By Application, By Method, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Cell-Free Protein Expression Market is predicted to reach 680.32 million by 2034 with a CAGR of 8.86%.

Cell-free protein expression, proteins can be synthesized in vitro without the use of living cells. Instead of depending on the cellular machinery of whole organisms, this technique employs extracted components-such as ribosomes, tRNAs, amino acids, and enzymes-from sources like E. coli, wheat germ, or insect cells. These components preserve the ability to transcribe DNA into RNA and translate RNA into proteins, enabling researchers to generate proteins rapidly and in a controlled environment.

Restraints: The limited scalability of the global cell-free protein expression market poses a major challenge. While cell-free systems work well for small-scale applications, they often struggle to generate the high yields needed for industrial production. This leads to economic difficulties for large-scale synthesis due to the need for extensive optimization and the use of costly reagents in significant amounts.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Application, By Method, By End Use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

biotechrabbit, CellFree Sciences Co., Ltd., GeneCopoeia, Inc., Jena Bioscience GmbH, Merck KGaA, New England Biolabs, Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific, Inc.

Global Cell-Free Protein Expression Market Segmentation:

By Product: Based on the Product, Global Cell-Free Protein Expression Market is segmented as; Expression Systems, Reagents.

By Application: Based on the Application, Global Cell-Free Protein Expression Market is segmented as; Enzyme Engineering, High Throughput Production, Protein Labelling, Protein-Protein Interaction, Protein Purification.

By Method: Based on the Method, Global Cell-Free Protein Expression Market is segmented as; Transcription & Translation systems, Translation systems.

By End Use: Based on the End Use, Global Cell-Free Protein Expression Market is segmented as; Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1.Introduction

  • 1.1.Scope of the report
  • 1.2.Market segment analysis

2.Research Methodology

  • 2.1.Research data source
    • 2.1.1.Secondary Data
    • 2.1.2.Primary Data
    • 2.1.3.SPERs internal database
    • 2.1.4.Premium insight from KOLs
  • 2.2.Market size estimation
    • 2.2.1.Top-down and Bottom-up approach
  • 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

  • 4.1.Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1.Drivers
    • 4.1.2.Restraints
    • 4.1.3.Opportunities
    • 4.1.4.Challenges

5.Market variable and outlook

  • 5.1.SWOT Analysis
    • 5.1.1.Strengths
    • 5.1.2.Weaknesses
    • 5.1.3.Opportunities
    • 5.1.4.Threats
  • 5.2.PESTEL Analysis
    • 5.2.1.Political Landscape
    • 5.2.2.Economic Landscape
    • 5.2.3.Social Landscape
    • 5.2.4.Technological Landscape
    • 5.2.5.Environmental Landscape
    • 5.2.6.Legal Landscape
  • 5.3.PORTERs Five Forces
    • 5.3.1.Bargaining power of suppliers
    • 5.3.2.Bargaining power of buyers
    • 5.3.3.Threat of Substitute
    • 5.3.4.Threat of new entrant
    • 5.3.5.Competitive rivalry
  • 5.4.Heat Map Analysis

6.Competitive Landscape

  • 6.1.Global Cell- Free Protein Expression Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cell- Free Protein Expression Market

7.Global Cell- Free Protein Expression Market, By Product (USD Million) 2021-2034

  • 7.1.Expression Systems
  • 7.2.Reagents

8.Global Cell- Free Protein Expression Market, By Application (USD Million) 2021-2034

  • 8.1.Enzyme Engineering
  • 8.2.High Throughput Production
  • 8.3.Protein Labeling
  • 8.4.Protein-Protein Interaction
  • 8.5.Protein Purification

9.Global Cell- Free Protein Expression Market, By Method (USD Million) 2021-2034

  • 9.1.Transcription & Translation systems
  • 9.2.Translation systems

10.Global Cell- Free Protein Expression Market, By End Use (USD Million) 2021-2034

  • 10.1.Pharmaceutical and Biotechnology Companies
  • 10.2.Academic and Research Institutes
  • 10.3.Others

11.Global Cell- Free Protein Expression Market, (USD Million) 2021-2034

  • 11.1.Global Cell- Free Protein Expression Market Size and Market Share

12.Global Cell- Free Protein Expression Market, By Region, (USD Million) 2021-2034

  • 12.1.Asia-Pacific
    • 12.1.1.Australia
    • 12.1.2.China
    • 12.1.3.India
    • 12.1.4.Japan
    • 12.1.5.South Korea
    • 12.1.6.Rest of Asia-Pacific
  • 12.2.Europe
    • 12.2.1.France
    • 12.2.2.Germany
    • 12.2.3.Italy
    • 12.2.4.Spain
    • 12.2.5.United Kingdom
    • 12.2.6.Rest of Europe
  • 12.3.Middle East and Africa
    • 12.3.1.Kingdom of Saudi Arabia
    • 12.3.2.United Arab Emirates
    • 12.3.3.Qatar
    • 12.3.4.South Africa
    • 12.3.5.Egypt
    • 12.3.6.Morocco
    • 12.3.7.Nigeria
    • 12.3.8.Rest of Middle-East and Africa
  • 12.4.North America
    • 12.4.1.Canada
    • 12.4.2.Mexico
    • 12.4.3.United States
  • 12.5.Latin America
    • 12.5.1.Argentina
    • 12.5.2.Brazil
    • 12.5.3.Rest of Latin America

13.Company Profile

  • 13.1.biotechrabbit
    • 13.1.1.Company details
    • 13.1.2.Financial outlook
    • 13.1.3.Product summary
    • 13.1.4.Recent developments
  • 13.2.CellFree Sciences Co., Ltd
    • 13.2.1.Company details
    • 13.2.2.Financial outlook
    • 13.2.3.Product summary
    • 13.2.4.Recent developments
  • 13.3.GeneCopoeia, Inc.
    • 13.3.1.Company details
    • 13.3.2.Financial outlook
    • 13.3.3.Product summary
    • 13.3.4.Recent developments
  • 13.4.Jena Bioscience GmbH
    • 13.4.1.Company details
    • 13.4.2.Financial outlook
    • 13.4.3.Product summary
    • 13.4.4.Recent developments
  • 13.5.Merck KGaA,
    • 13.5.1.Company details
    • 13.5.2.Financial outlook
    • 13.5.3.Product summary
    • 13.5.4.Recent developments
  • 13.6.New England Biolabs
    • 13.6.1.Company details
    • 13.6.2.Financial outlook
    • 13.6.3.Product summary
    • 13.6.4.Recent developments
  • 13.7.Promega Corporation
    • 13.7.1.Company details
    • 13.7.2.Financial outlook
    • 13.7.3.Product summary
    • 13.7.4.Recent developments
  • 13.8.Takara Bio Inc.
    • 13.8.1.Company details
    • 13.8.2.Financial outlook
    • 13.8.3.Product summary
    • 13.8.4.Recent developments
  • 13.9.Thermo Fisher Scientific, Inc.
    • 13.9.1.Company details
    • 13.9.2.Financial outlook
    • 13.9.3.Product summary
    • 13.9.4.Recent developments
  • 13.10.Others

14.Conclusion

15.List of Abbreviations

16.Reference Links